Pesquisas alternativas:
safety one » safety zone (Expandir a Pesquisa), safety zones (Expandir a Pesquisa), safety over (Expandir a Pesquisa)
one armed » one arm (Expandir a Pesquisa)
case r » case 1 (Expandir a Pesquisa)
case 2 » case _ (Expandir a Pesquisa), case 1 (Expandir a Pesquisa)
safety one » safety zone (Expandir a Pesquisa), safety zones (Expandir a Pesquisa), safety over (Expandir a Pesquisa)
one armed » one arm (Expandir a Pesquisa)
case r » case 1 (Expandir a Pesquisa)
case 2 » case _ (Expandir a Pesquisa), case 1 (Expandir a Pesquisa)
161
Por Raymond, Eric, Brandes, Alba A., Dittrich, Christian, Fumoleau, Pierre, Coudert, Bruno, Clement, Paul M.J., Frenay, Marc, Rampling, Roy, Stupp, Roger, Kros, Johan M., Heinrich, Michael C., Gorlia, Thierry, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2008
“.... PATIENTS AND METHODS: This was a single-arm, phase II study. Eligible patients had recurrent glioma after...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
162
Por Ulrika Morris, Mwinyi I. Msellem, Humphrey Mkali, Atiqul Islam, Berit Aydin-Schmidt, Irina Jovel, Shija Joseph Shija, Mwinyi Khamis, Safia Mohammed Ali, Lamija Hodzic, Ellinor Magnusson, Eugenie Poirot, Adam Bennett, Michael C. Sachs, Joel Tarning, Andreas Mårtensson, Abdullah S. Ali, Anders Björkman
Publicado em 2018-12-01
“... to determine the effectiveness and safety of two rounds of MDA in Zanzibar, a pre-elimination setting. Methods...”Publicado em 2018-12-01
Obter o texto integral
Artigo
163
Por Dunn, Conor, Faloon, Michael, Milman, Edward, Pourtaheri, Sina, Sinah, Kumar, Hwang, Ki, Emami, Arash
Publicado no Asian Spine J (2018)
“...STUDY DESIGN: Retrospective case series with prospective arm. PURPOSE: To assess the safety...”Publicado no Asian Spine J (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
164
Por Lolli, Cristian, Gallà, Valentina, Schepisi, Giuseppe, Barone, Domenico, Burgio, Salvatore Luca, Maugeri, Antonio, Vertogen, Bernadette, Amadori, Dino, De Giorgi, Ugo
Publicado no Oncologist (2017)
“... have conducted an open‐label, single‐arm, phase II trial of prednisone 5 mg b.i.d. added to everolimus...”Publicado no Oncologist (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
165
Por Karlsson, Goeril, Francis, Gordon, Koren, Gideon, Heining, Peter, Zhang, Xiaoli, Cohen, Jeffrey A., Kappos, Ludwig, Collins, William
Publicado em 2014
“... with an unknown outcome (patient lost to follow-up). Two infants were born with malformations: 1 with congenital...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
166
“... of vascular endothelial growth factor-A (anti-VEGF agents). One such agent in widespread use is bevacizumab...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
167
Por Norsworthy, Kelly J., Ko, Chia‐Wen, Lee, Jee Eun, Liu, Jiang, John, Christy S., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Publicado no Oncologist (2018)
“... with R/R AML showed that a lower‐dose “fractionated” schedule of 3 mg/m(2) days 1, 4, and 7...”Publicado no Oncologist (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
168
“... place between long arm of PZ (composed of GLA, EGF1, and EGF2 domains) and GLA domain of FXa. In our...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
169
“... or 5.8 GHz ISM frequency band. Two sensors have a fixed location: one on the head (earlobe pulse oximetry...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
170
Por Aseffa, Abraham, Chukwu, Joseph N., Vahedi, Mahnaz, Aguwa, Emmanuel N., Bedru, Ahmed, Mebrahtu, Tesfamariam, Ezechi, Oliver C., Yimer, Getnet, Yamuah, Lawrence K., Medhin, Girmay, Connolly, Cathy, Rida, Wasima, Aderaye, Getachew, Zumla, Alimuddin I., Onyebujoh, Philip C.
Publicado no PLoS One (2016)
“...) versus LF 96.9% (345/356), (difference 2.0% (90% CI: 0.1%– 3.8%)). The two arms showed no significant...”Publicado no PLoS One (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
171
Por Michel, Martin C, Minarzyk, Anette, Schwerdtner, Inka, Quail, Deborah, Methfessel, Hans D, Weber, Hans-Joachim
Publicado em 2013
Assuntos:
“...Drug Safety...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
172
Por Fan, Dazhi, Wu, Shuzhen, Ye, Shaoxin, Wang, Wen, Guo, Xiaoling, Liu, Zhengping
Publicado no Medicine (Baltimore) (2017)
“... with 2 arms. One hundred twenty primiparous participants will be randomly (1:1 ratio) assigned to receive...”Publicado no Medicine (Baltimore) (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
173
Por Rinciog, C., Watkins, M., Chang, S., Maher, T. M., LeReun, C., Esser, D., Diamantopoulos, A.
Publicado no Pharmacoeconomics (2016)
“... of nintedanib clinical trials (TOMORROW, INPULSIS-1, INPULSIS-2). A network meta-analysis (NMA) was conducted...”Publicado no Pharmacoeconomics (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
174
Por Carcas, Antonio J, Borobia, Alberto M, Velasco, Marta, Abad-Santos, Francisco, Díaz, Manuel Quintana, Fernández-Capitán, Carmen, Ruiz-Giménez, Nuria, Madridano, Olga, Sillero, Pilar Llamas
Publicado em 2012
“... with VTE in which oral anticoagulant therapy is indicated will be included. Randomization (case/control 1:1...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
175
Por Antonio Cuadrado-Lavín, José Manuel Olmos, José Manuel Cifrian, Teresa Gimenez, Marco Antonio Gandarillas, Mar García-Saiz, Maria Henar Rebollo, Victor Martínez-Taboada, Marcos López-Hoyos, María Carmen Fariñas, Javier Crespo
Publicado em 2020-06-01
“...) Intervention: (n = 225): One 200 mg hydroxychloroquine sulfate coated tablet once daily for two months. 2...”Publicado em 2020-06-01
Obter o texto integral
Artigo
176
Por Obermair, Andreas, Brennan, Donal J., Baxter, Eva, Armes, Jane E., Gebski, Val, Janda, Monika
Publicado no Gynecol Oncol Res Pract (2016)
“... loss as primary treatment. METHODS: Consecutive case series from a tertiary gynaecological oncology...”Publicado no Gynecol Oncol Res Pract (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
177
Por Ibrahim, Ahmed, Elhilali, Mostafa M., Elkoushy, Mohammed A., Andonian, Sero, Carrier, Serge
Publicado no Can Urol Assoc J (2019)
“... in complication rates (2.4% vs. 7.3 %; p=0.1). However, there was one case of bladder perforation requiring...”Publicado no Can Urol Assoc J (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
178
Por Paola Di Mascio, Giuseppe Loprencipe, Laura Moretti, Maria Vittoria Corazza, Sergio Vivaldi, Giovanni Vincenti
Publicado em 2018-02-01
“... and safety needs; high-traffic ones for the chosen pavement type; airport ones for the absence of dowel...”Publicado em 2018-02-01
Obter o texto integral
Artigo
179
“... of the SMART-AF trial was performed using the data sets, data dictionary, case report file, and statistical...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
180
“...INTRODUCTION: Although the safety of celecoxib has been investigated, limited data are available...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo